Evidence map›Paper›PMID 40111459›Full record

ArticleMedizinische Klinik, Intensivmedizin und Notfallmedizin2025

[Recommendations on standard concentrations for continuous infusion of medicinal products in intensive care units].

L Kreysing, H Hilgarth, M Bodenstein, N Haake, A Kaltwasser, J A Köck, D Meyn, R Riessen, C Waydhas, I Krämer

Abstract readEnglish Abstract
In one paragraph

Article in Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

L KreysingApotheke der Universitätsmedizin Mainz, Johannes Gutenberg-Universität, Langenbeckstraße 1, 55131, Mainz, Deutschland.
H HilgarthADKA Akademie für Krankenhauspharmazie, Bundesverband Deutscher Krankenhausapotheker e. V. (ADKA), Berlin, Deutschland.
M BodensteinKlinik für Anästhesiologie Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz, Mainz, Deutschland.
N HaakePraxis für Herz-Kreislauf-Sportmedizin und Perioperative Medizin, Kiel, Deutschland.
A KaltwasserAkademie der Kreiskliniken Reutlingen gGmbH, Reutlingen, Deutschland.
J A KöckApotheke des Universitätsklinikums Erlangen, Erlangen, Deutschland.
D MeynGesundheit Nordhessen Holding AG, Kassel, Deutschland.
R RiessenDepartment für Innere Medizin, Universitätsklinikum Tübingen, Tübingen, Deutschland.
C WaydhasKlinik für Unfall‑, Hand- und Wiederherstellungschirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Deutschland.
I KrämerApotheke der Universitätsmedizin Mainz, Johannes Gutenberg-Universität, Langenbeckstraße 1, 55131, Mainz, Deutschland. irene.kraemer@unimedizin-mainz.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNumerous medications are continuously administered to intensive care patients. To minimize medication errors standardized concentrations and dose adjustment by the infusion rate are recommended. This principle is already widely accepted in German intensive care units (ICUs). However, the active ingredients and concentrations used are still heterogeneous throughout the country.

aimThe aim of the ADKA/DIVI (Bundesverband Deutscher Krankenhausapotheker/Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin) initiative was to create a nationwide standard for adult continuous intravenous infusions in German ICUs by an expert panel. MATERIALS AND

methodsA mandated group of experts developed a nationwide standard concentration list for continuous infusion in a two-stage, consensus-based process. In stage 1, the inclusion of active substances was agreed upon, and in stage 2, the standard concentrations to be recommended were decided upon. The decision-making process was based on predefined decision criteria.

resultsThe continuous infusion standard contains 41 active substances with 49 standard concentrations (37 substances with 1 concentration [conc.], heparin 2 conc., epinephrine and sufentanil 3 conc., norepinephrine 4 conc.), along with the appropriate vehicle solution, and the physicochemical stability over maximum 24 h.

conclusionThe resulting continuous infusion standards are practical and evidence-based and represent a central component for improving medication safety in ICUs. Implementation of the standard list in German ICUs should be facilitated by interdisciplinary teams.

Indexed as

Critical CareIntensive Care UnitsAdultGermanyHumansInfusions, IntravenousMedication ErrorsPharmaceutical PreparationsPharmaceutical PreparationsContinuous infusionDrug therapy safetyEvidence-based decision-making processIntensive care patientsStandard concentrations

Identifiers

PMID40111459
PMCPMC11961480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.